بدائل البحث:
cases increased » rate increased (توسيع البحث), levels increased (توسيع البحث)
large decrease » marked decrease (توسيع البحث), large increases (توسيع البحث), large degree (توسيع البحث)
152 cases » 19 cases (توسيع البحث), 16 cases (توسيع البحث), 1 cases (توسيع البحث)
c large » _ large (توسيع البحث), a large (توسيع البحث), _ larger (توسيع البحث)
i large » _ large (توسيع البحث), a large (توسيع البحث), via large (توسيع البحث)
b large » _ large (توسيع البحث), a large (توسيع البحث), _ larger (توسيع البحث)
cases increased » rate increased (توسيع البحث), levels increased (توسيع البحث)
large decrease » marked decrease (توسيع البحث), large increases (توسيع البحث), large degree (توسيع البحث)
152 cases » 19 cases (توسيع البحث), 16 cases (توسيع البحث), 1 cases (توسيع البحث)
c large » _ large (توسيع البحث), a large (توسيع البحث), _ larger (توسيع البحث)
i large » _ large (توسيع البحث), a large (توسيع البحث), via large (توسيع البحث)
b large » _ large (توسيع البحث), a large (توسيع البحث), _ larger (توسيع البحث)
-
121
-
122
Supplementary Material for: High-sensitivity Troponin I Measurement in a Large Contemporary Cohort: Implications for Clinical Care
منشور في 2025"…Male sex, higher HDL-C, higher Hgb A1c, decreasing eGFR, and increasing systolic blood pressure were significant predictors of increased hsTnI. …"
-
123
-
124
-
125
-
126
-
127
Table 1_Cholesterol metabolic reprogramming drives the onset of DLBCL and represents a promising therapeutic target.docx
منشور في 2025"…</p>Methods<p>We retrospectively analyzed clinical data from 200 DLBCL patients and 185 healthy controls, focusing on lipid and lipoprotein levels, including triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB), and apolipoprotein E (ApoE). …"
-
128
-
129
-
130
-
131
Data Sheet 1_Cholesterol metabolic reprogramming drives the onset of DLBCL and represents a promising therapeutic target.docx
منشور في 2025"…</p>Methods<p>We retrospectively analyzed clinical data from 200 DLBCL patients and 185 healthy controls, focusing on lipid and lipoprotein levels, including triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB), and apolipoprotein E (ApoE). …"
-
132
-
133
-
134
Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.
منشور في 2025الموضوعات: -
135
-
136
Supplementary Material for: STAT3 Promotes Cell Proliferation by Potentiating the CCL4 Transcriptional Activity in Diffuse Large B-Cell Lymphoma
منشور في 2021"…However, the underlying mechanism of STAT3 in the pathogenesis of diffuse large B-cell lymphoma (DLBCL) has yet to be established. …"
-
137
Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.
منشور في 2025الموضوعات: -
138
Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.
منشور في 2025الموضوعات: -
139
-
140
The percentages of genes with largely changed expression after AdNKX2-1 infection.
منشور في 2021الموضوعات: